|
End-of-day quote
Amman S.E.
2026-08-23
|
5-day change | 1st Jan Change | ||
| 1.840 JOD | 0.00% |
|
-7.07% | +15.00% |
| 07-21 | Philadelphia Pharmaceuticals Company Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-27 | Philadelphia Pharmaceuticals Q1 profit 255,632 dinars | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | 0.00% | -7.07% | -8.00% | +6.98% | +15.00% | +26.03% | +29.58% | +33.33% | -39.67% | 19.48M | |
| +0.74% | +2.04% | -1.07% | +4.34% | +11.67% | +15.92% | +71.72% | +148.97% | +149.50% | 47.71B | |
| +0.37% | +1.83% | +9.68% | +6.16% | +37.89% | +52.56% | +123.63% | +158.01% | +163.51% | 40.3B | |
| -0.17% | -0.05% | +1.43% | +1.20% | -5.33% | -10.64% | +17.23% | +55.92% | +152.26% | 12.09B | |
| -0.98% | -1.90% | +0.12% | +3.45% | +21.40% | +8.49% | +73.21% | +102.22% | +194.94% | 11.68B | |
| +0.19% | +0.58% | -0.38% | +0.58% | +28.08% | +30.98% | +158.71% | +135.29% | +339.19% | 9.19B | |
| -0.39% | -0.92% | +10.56% | +7.33% | +30.56% | +20.49% | +38.72% | +41.62% | +130.00% | 7.57B | |
| 0.00% | +1.56% | +0.45% | +0.33% | +12.59% | +46.86% | -11.57% | -6.36% | -14.83% | 7.24B | |
| +1.51% | +1.03% | +7.34% | +0.68% | +15.62% | +20.29% | +214.09% | +351.07% | +174.80% | 6.84B | |
| -5.36% | -6.36% | -6.52% | -7.55% | -34.05% | -38.04% | +22.49% | +30.25% | +13.31% | 5.42B | |
| -2.19% | -4.15% | +5.77% | +15.65% | +28.71% | +35.92% | +107.47% | +142.42% | +167.26% | 4.75B | |
| +2.78% | +2.75% | -1.28% | +8.96% | +26.41% | +41.88% | -21.19% | -20.94% | -59.25% | 4.09B | |
| -3.81% | -5.98% | -8.64% | +13.24% | -2.84% | -21.42% | +77.56% | +46.11% | - | 3.96B | |
| -0.02% | -0.50% | +2.17% | +15.37% | +30.64% | +30.40% | +701.06% | +322.43% | +135.22% | 3.2B | |
| 0.00% | -1.08% | +9.21% | +4.17% | -2.96% | -5.04% | +50.77% | +215.73% | +743.04% | 2.93B | |
| -7.71% | -10.74% | +1.57% | -54.65% | -27.44% | -3.76% | +198.06% | +184.97% | +1,621.43% | 2.85B | |
| +0.52% | +4.95% | +16.91% | +1.42% | -15.39% | -25.81% | +56.47% | +95.58% | +15.18% | 2.83B | |
| -1.79% | -2.76% | -8.53% | -10.58% | -5.68% | +5.42% | +57.34% | +9.96% | +67.12% | 2.63B | |
| +1.35% | +0.85% | +0.21% | -6.98% | +0.28% | -9.51% | +25.40% | - | - | 2.66B | |
| -4.15% | -5.09% | +3.43% | -10.50% | +9.54% | -44.61% | +96.00% | +46.92% | - | 2.45B | |
| Average | -0.94% | -1.42% | +1.72% | -0.02% | +8.73% | +8.82% | +104.34% | +110.18% | +232.53% | 9.02B | |
| Weighted average by Cap. | -0.11% | -0.61% | +2.84% | +2.98% | +16.53% | +20.49% | +94.37% | +128.27% | +181.53% |
- Stock Market
- Stocks
- PHIL Stock
- Sector Philadelphia Pharmaceuticals Company
Select your edition
All financial news and data tailored to specific country editions
